BPG is committed to discovery and dissemination of knowledge
Case Report
Copyright: ©Author(s) 2026.
World J Clin Oncol. Nov 24, 2026; 17(11): 124859
Published online Nov 24, 2026. doi: 10.5306/wjco.124859
Figure 1
Figure 1 Computed tomography and magnetic resonance imaging findings of the mass at the hepatic–adrenal interface. A: Non-contrast computed tomography shows an elliptical, mixed-density shadow in the right lobe of the liver and the right adrenal region; B: Contrast-enhanced computed tomography shows no enhancement of the fatty component in the lesion, with some enhancement of the hematopoietic component; C: Gadolinium magnetic resonance imaging T1-weighted scan shows a hyperintense signal in the fatty component, and an isointense signal in the hematopoietic component; D: Gadolinium magnetic resonance imaging T2-weighted scan shows a hyperintense signal in the hematopoietic component.
Figure 2
Figure 2 Three-dimensional reconstructed images of the liver, adrenal gland, and mass. A: Anterior view; yellow: Hepatic myelolipoma (HM), pink part: Adrenal gland; B: Right view; yellow part: HM, pink part: Adrenal gland; C: Left view; blue part: Left hepatic lobe, purple part: Right hepatic lobe, yellow part: Mass, pink part: Adrenal gland; D: Back view; blue part: Left hepatic lobe, purple part: Right hepatic lobe, yellow part: HM, pink part: Adrenal gland.
Figure 3
Figure 3 Microscopic views of resected specimens with hematoxylin and eosin staining. A: Normal liver parenchyma (blue arrows) and myelolipoma (yellow arrows), 10 × magnification; B: The myelolipoma comprises adipose and hematopoietic tissues, including megakaryocytes and myelopoiesis, 40 × magnification; C: The tumor is observed within the capsule (blue arrows) consisting of adipose and myelopoietic tissues (white arrow), with a small amount of adrenal tissue (black arrow) in the immediate inner area of the capsule; 20 × magnification.


Write to the Help Desk